stars 1 stars 2 stars 3

At Oculox Technologies SA we are Leading Innovation in Ophthalmology. We are dedicated to revolutionising treatment options for eye diseases. Together, we are redefining standards of care, ensuring a brighter future for us all. Our Goal is to establish a comprehensive eye-healthcare platform from early diagnosis to effective treatment, ensuring global holistic care solutions. RetinaWISE is a new medical instrument that combines cutting-edge pupillometry with specific scotopic light stimuli to evaluate and support the diagnosis of early-onset retinal and neuroretinal disorders. RetinaSEES is a clinical-stage therapeutic device that utilises an advanced multimodal laser therapy to offer an effective alternative for intermediate Age-related Macular Degeneration (AMD).

Oculox Technologies Questions

Filippo Piffaretti is the CEO of Oculox Technologies.

9 people are employed at Oculox Technologies.

Oculox Technologies is based in Muzzano, Ticino.

The NAICS codes for Oculox Technologies are [541713, 541, 54171, 54, 5417].

The SIC codes for Oculox Technologies are [87, 873].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users